Abstract
The lead optimization process to identify new selective dopamine D3 receptor antagonists is reported. DMPK parameters and binding data suggest that selective D3 receptor antagonists as potential PET ligands might have been identified.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have